The Second Affiliated Hospital of Zhejiang University College

HangzhouZhejiang 310009

1 studies enrolling now · 1 studies all time

What they study most

HER2-positive Breast Cancer

Studies at this site

• RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive — Recruiting now